David H Margolin

Title: David H Margolin: Innovator in Thyroid Disorder Risk Identification

Introduction

David H Margolin is a notable inventor based in Somerville, MA (US). He has made significant contributions to the field of medical diagnostics, particularly in identifying risks associated with thyroid disorders. With a total of 3 patents, his work has the potential to impact patient care and treatment outcomes.

Latest Patents

One of David H Margolin's latest patents is a method for identifying patients at risk for developing thyroid disorders following treatments that deplete lymphocytes. This method involves determining the presence of antibodies directed against thyroid peroxidase or thyroid microsomes in the patient. If these antibodies are present, the patient is considered to be at an increased risk for developing a thyroid disorder. A specific application of this method is for patients with multiple sclerosis who are at risk for thyroid disorders after receiving treatments that deplete CD52-positive cells.

Career Highlights

Throughout his career, David H Margolin has worked with prominent companies such as Genzyme Corporation and Alcafleu Management GmbH & Co. KG. His experience in these organizations has contributed to his expertise in medical innovation and patent development.

Collaborations

David has collaborated with notable professionals in his field, including Walter Hong and Alasdair J Coles. These collaborations have likely enriched his research and development efforts.

Conclusion

David H Margolin is a distinguished inventor whose work in identifying risks for thyroid disorders showcases his commitment to advancing medical diagnostics. His contributions are valuable to both the medical community and patients alike.